SEC Form 4 · accession 0001209191-18-053871
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H. Reilly
Officer — SVP & Chief Operating Officer
Period of report
Oct 1, 2018
Accepted (ET)
Oct 3, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2018 | M | 15,000 | $4.71 | A | 29,177 | D | |
| Common Stock | Oct 1, 2018 | M | 10,000 | $5.19 | A | 39,177 | D | |
| Common StockF2 | Oct 1, 2018 | S | 23,300 | $12.02 | D | 15,877 | D | |
| Common StockF3 | Oct 1, 2018 | S | 1,700 | $12.62 | D | 14,177 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4 | $4.71 | Oct 1, 2018 | M | 15,000 | D | — | Dec 3, 2025 | Common Stock | 15,000 | 27,400 | D |
| Employee Stock Option (Right to Buy)F5 | $5.19 | Oct 1, 2018 | M | 10,000 | D | — | Apr 13, 2025 | Common Stock | 10,000 | 47,524 | D |
Explanation of responses
- F1These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.60 to $12.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.60 to $12.69, inclusive.
- F4This option vested 25% on December 4, 2016 and then in quarterly installments over 3 years thereafter.
- F5This option vested 25% on April 14, 2016 and then in quarterly installments over 3 years thereafter.